{"id":26654,"date":"2025-01-20T13:41:20","date_gmt":"2025-01-20T16:41:20","guid":{"rendered":"https:\/\/femama.org.br\/site\/?p=26654"},"modified":"2025-01-24T17:33:51","modified_gmt":"2025-01-24T20:33:51","slug":"esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil","status":"publish","type":"post","link":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/","title":{"rendered":"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar:"},"content":{"rendered":"<p><span style=\"color: #000000;\"><span style=\"font-weight: 400;\">A Consulta P\u00fablica n<\/span><span style=\"font-weight: 400;\">o <\/span><span style=\"font-weight: 400;\">144, da ANS, que encerra no dia 24\/01\/25, prop\u00f5e como um dos crit\u00e9rios a serem avaliados para fins de certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia para a sa\u00fade suplementar a realiza\u00e7\u00e3o de rastreamento de c\u00e2ncer de mama, a cada dois anos, por mamografia, em mulheres com idade entre 50 e 69 anos, que \u00e9 a recomenda\u00e7\u00e3o do Instituto Nacional do C\u00e2ncer (INCA), mas difere do Rol de Procedimentos da pr\u00f3pria ANS, que d\u00e1 direito ao exame de rastreio para mulheres de 40 a 69 anos. O texto da consulta p\u00fablica tem gerado d\u00favidas e um amplo debate p\u00fablico, ao oferecer um servi\u00e7o a partir de uma diretriz (Rol ANS), mas propor certificar as boas pr\u00e1ticas a partir de outra (INCA).\u00a0<\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-weight: 400;\">Considerando que 40% dos diagn\u00f3sticos de c\u00e2ncer de mama em mulheres brasileiras s\u00e3o realizados abaixo dos 50 anos e 22% das mortes acontecem neste grupo, o CBR &#8211; Col\u00e9gio Brasileiro de Radiologia, a SBM &#8211; Sociedade Brasileira de Mastologia, a FEBRASGO &#8211; Federa\u00e7\u00e3o Brasileira de Associa\u00e7\u00f5es de Ginecologistas e Obstetras e a Sociedade Brasileira de Oncologia Cl\u00ednica defendem fortemente o <\/span><b>rastreamento mamogr\u00e1fico anual para todas as mulheres entre 40 e 69 anos<\/b><span style=\"font-weight: 400;\">, inclusive no SUS, conforme garantido pela Lei n\u00b0 14.335 de 2022.<\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-weight: 400;\">A FEMAMA &#8211; Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama se posiciona institucionalmente a favor de uma certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia, mas CONTRA o ARTIGO III CAP\u00cdTULO II da Consulta P\u00fablica n\u00ba 144, que recomenda como crit\u00e9rio de avalia\u00e7\u00e3o o rastreamento<\/span><span style=\"font-weight: 400;\">\u00a0bienal entre 50 e 69 anos e considera que este item representa um retrocesso, uma vez que atualmente a maioria das operadoras de sa\u00fade j\u00e1 segue a recomenda\u00e7\u00e3o de rastreamento anual, a partir de 40 anos. Considerando que a diferen\u00e7a na taxa de sobrevida para mulheres entre 40-50 anos que tiveram seu diagn\u00f3stico pelo rastreamento mamogr\u00e1fico \u00e9 de 25% a mais em 10 anos, o \u00fanico benef\u00edcio da altera\u00e7\u00e3o da diretriz proposta com a certifica\u00e7\u00e3o \u00e9 a redu\u00e7\u00e3o de custos com exames para as operadoras. Vale ressaltar, ainda, que os custos com diagn\u00f3sticos avan\u00e7ados a longo prazo n\u00e3o est\u00e3o sendo considerados.<\/span><\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000;\">Voc\u00ea pode fazer a diferen\u00e7a nesse processo! A resposta \u00e0 consulta p\u00fablica \u00e9 aberta para entidades de classe, m\u00e9dicos, pessoas f\u00edsicas e outras entidades. Participe e ajude a ampliar o diagn\u00f3stico precoce no Brasil:<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/p>\n<ol>\n<li><span style=\"font-weight: 400; color: #000000;\"> Acesse o link da Consulta P\u00fablica N\u00ba 144: <\/span><a href=\"https:\/\/componentes-portal.ans.gov.br\/link\/ConsultaPublica\/144\">https:\/\/componentes-portal.ans.gov.br\/link\/ConsultaPublica\/144<\/a><\/li>\n<li><span style=\"font-weight: 400; color: #000000;\"> Nele, voc\u00ea ter\u00e1 acesso a documentos relevantes, como a minuta de norma e a nota t\u00e9cnica.<\/span><\/li>\n<li><span style=\"font-weight: 400; color: #000000;\"> Logo abaixo, voc\u00ea encontrar\u00e1 o espa\u00e7o para contribuir.<\/span><\/li>\n<li><span style=\"font-weight: 400; color: #000000;\"> Ao entrar, preencha: nome, CPF ou CNPJ da sua institui\u00e7\u00e3o, e-mail e demais dados. Em seguida, selecione o tipo de contribui\u00e7\u00e3o que voc\u00ea vai fazer: pessoa interessada, paciente, profissional da sa\u00fade, familiar ou outros.<\/span><\/li>\n<li><span style=\"font-weight: 400; color: #000000;\"> Na sequ\u00eancia, aparecer\u00e1 o espa\u00e7o para votar e contribuir.<\/span><\/li>\n<li><span style=\"font-weight: 400; color: #000000;\"> No item de contribui\u00e7\u00e3o, selecione &#8220;ANEXO III: CAP\u00cdTULO II&#8221;.<\/span><\/li>\n<li><span style=\"font-weight: 400; color: #000000;\"> Agora \u00e9 a hora de expressar sua opini\u00e3o!\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400; color: #000000;\"> Posicione-se CONCORDANDO ou DISCORDANDO.<\/span><\/li>\n<li><span style=\"font-weight: 400; color: #000000;\"> Na sequ\u00eancia, justifique sua escolha. Escreva os motivos que melhor ilustram a sua contribui\u00e7\u00e3o na Consulta P\u00fablica.<\/span><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400; color: #000000;\">A FEMAMA DISCORDA da atualiza\u00e7\u00e3o que recomenda como crit\u00e9rio de boas pr\u00e1ticas em oncologia o rastreamento bienal de mulheres com idade entre 50 e 69 anos.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><b>Refer\u00eancias<\/b><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Lima SM, Kehm RD, Terry MB. Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns. EClinicalMedicine. 2021 Jul 7;38: 100985.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Simon SD, Bines J, Werutsky G, et al. Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study. Breast. 2019; 44: 113-119.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Rosa DD, Bines J, Werutsky G, et al. The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115). Breast Cancer Res Treat. 2020; 183(3): 749-757.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Urban LABD, Chala LF, de Paula IB, et al. Recommendations for breast cancer screening in Brazil, from the Brazilian College of Radiology and Diagnostic Imaging, the Brazilian Society of Mastology, and the Brazilian Federation of Gynecology and Obstetrics Associations. Radiol Bras. 2023;56(4): 207-214.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Urban LABD, Chala LF, Paula IB, et al. Recommendations for the Screening of Breast Cancer of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Society of Mastology and Brazilian Federation of Gynecology and Obstetrics Association. Rev Bras Ginecol Obstet. 2023 Aug;45(8): e480-e488.<\/span><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Consulta P\u00fablica no 144, da ANS, que encerra no dia 24\/01\/25, prop\u00f5e como um dos crit\u00e9rios a serem avaliados para fins de certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia para a sa\u00fade suplementar a realiza\u00e7\u00e3o de rastreamento de c\u00e2ncer de mama, a cada dois anos, por mamografia, em mulheres com idade entre 50 e 69 [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":26655,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[19,18,20,13],"tags":[],"class_list":["post-26654","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-advocacy","category-cancer-de-mama","category-direito-dos-pacientes","category-noticias-recentes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar: | FEMAMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar: | FEMAMA\" \/>\n<meta property=\"og:description\" content=\"A Consulta P\u00fablica no 144, da ANS, que encerra no dia 24\/01\/25, prop\u00f5e como um dos crit\u00e9rios a serem avaliados para fins de certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia para a sa\u00fade suplementar a realiza\u00e7\u00e3o de rastreamento de c\u00e2ncer de mama, a cada dois anos, por mamografia, em mulheres com idade entre 50 e 69 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/\" \/>\n<meta property=\"og:site_name\" content=\"FEMAMA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/femamabrasil\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-20T16:41:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-24T20:33:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2025\/01\/Consulta-Publica-n\u00b0-144-1024x512.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Femama\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@femama_\" \/>\n<meta name=\"twitter:site\" content=\"@femama_\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Femama\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/\"},\"author\":{\"name\":\"Femama\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\"},\"headline\":\"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar:\",\"datePublished\":\"2025-01-20T16:41:20+00:00\",\"dateModified\":\"2025-01-24T20:33:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/\"},\"wordCount\":773,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Consulta-Publica-n\u00b0-144.png\",\"articleSection\":[\"Advocacy\",\"C\u00e2ncer de Mama\",\"Direito dos Pacientes\",\"Not\u00edcias recentes\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/\",\"name\":\"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar: | FEMAMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Consulta-Publica-n\u00b0-144.png\",\"datePublished\":\"2025-01-20T16:41:20+00:00\",\"dateModified\":\"2025-01-24T20:33:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/#primaryimage\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Consulta-Publica-n\u00b0-144.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Consulta-Publica-n\u00b0-144.png\",\"width\":6912,\"height\":3456},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/noticias-recentes\\\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar:\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"name\":\"FEMAMA\",\"description\":\"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"publisher\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/femama.org.br\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#organization\",\"name\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"contentUrl\":\"https:\\\/\\\/femama.org.br\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/logotipo-femama-horizontal.png\",\"width\":300,\"height\":92,\"caption\":\"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama\"},\"image\":{\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/femamabrasil\",\"https:\\\/\\\/x.com\\\/femama_\",\"https:\\\/\\\/www.instagram.com\\\/femama.brasil\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/femamaorg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/femama.org.br\\\/site\\\/#\\\/schema\\\/person\\\/ed83a17236fa12a9cfd26890f0e3474e\",\"name\":\"Femama\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g\",\"caption\":\"Femama\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar: | FEMAMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/","og_locale":"pt_BR","og_type":"article","og_title":"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar: | FEMAMA","og_description":"A Consulta P\u00fablica no 144, da ANS, que encerra no dia 24\/01\/25, prop\u00f5e como um dos crit\u00e9rios a serem avaliados para fins de certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia para a sa\u00fade suplementar a realiza\u00e7\u00e3o de rastreamento de c\u00e2ncer de mama, a cada dois anos, por mamografia, em mulheres com idade entre 50 e 69 [&hellip;]","og_url":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/","og_site_name":"FEMAMA","article_publisher":"https:\/\/www.facebook.com\/femamabrasil","article_published_time":"2025-01-20T16:41:20+00:00","article_modified_time":"2025-01-24T20:33:51+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2025\/01\/Consulta-Publica-n\u00b0-144-1024x512.png","type":"image\/png"}],"author":"Femama","twitter_card":"summary_large_image","twitter_creator":"@femama_","twitter_site":"@femama_","twitter_misc":{"Escrito por":"Femama","Est. tempo de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/#article","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/"},"author":{"name":"Femama","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e"},"headline":"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar:","datePublished":"2025-01-20T16:41:20+00:00","dateModified":"2025-01-24T20:33:51+00:00","mainEntityOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/"},"wordCount":773,"commentCount":0,"publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"image":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2025\/01\/Consulta-Publica-n\u00b0-144.png","articleSection":["Advocacy","C\u00e2ncer de Mama","Direito dos Pacientes","Not\u00edcias recentes"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/","url":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/","name":"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar: | FEMAMA","isPartOf":{"@id":"https:\/\/femama.org.br\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/#primaryimage"},"image":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/#primaryimage"},"thumbnailUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2025\/01\/Consulta-Publica-n\u00b0-144.png","datePublished":"2025-01-20T16:41:20+00:00","dateModified":"2025-01-24T20:33:51+00:00","breadcrumb":{"@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/#primaryimage","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2025\/01\/Consulta-Publica-n\u00b0-144.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2025\/01\/Consulta-Publica-n\u00b0-144.png","width":6912,"height":3456},{"@type":"BreadcrumbList","@id":"https:\/\/femama.org.br\/site\/noticias-recentes\/esta-aberta-uma-consulta-publica-sobre-rastreio-mamografico-na-saude-suplementar-participe-e-contribua-para-ampliar-o-diagnostico-precoce-no-brasil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/femama.org.br\/site\/"},{"@type":"ListItem","position":2,"name":"Posicionamento FEMAMA sobre crit\u00e9rio de rastreamento mamogr\u00e1fico para certifica\u00e7\u00e3o de boas pr\u00e1ticas em oncologia na sa\u00fade suplementar:"}]},{"@type":"WebSite","@id":"https:\/\/femama.org.br\/site\/#website","url":"https:\/\/femama.org.br\/site\/","name":"FEMAMA","description":"Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","publisher":{"@id":"https:\/\/femama.org.br\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/femama.org.br\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/femama.org.br\/site\/#organization","name":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama","url":"https:\/\/femama.org.br\/site\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/","url":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","contentUrl":"https:\/\/femama.org.br\/site\/wp-content\/uploads\/2021\/12\/logotipo-femama-horizontal.png","width":300,"height":92,"caption":"Femama | Federa\u00e7\u00e3o Brasileira de Institui\u00e7\u00f5es Filantr\u00f3picas de Apoio \u00e0 Sa\u00fade da Mama | C\u00e2ncer de mama"},"image":{"@id":"https:\/\/femama.org.br\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/femamabrasil","https:\/\/x.com\/femama_","https:\/\/www.instagram.com\/femama.brasil\/","https:\/\/www.youtube.com\/user\/femamaorg"]},{"@type":"Person","@id":"https:\/\/femama.org.br\/site\/#\/schema\/person\/ed83a17236fa12a9cfd26890f0e3474e","name":"Femama","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fd7fd20674373e7845d94c5ca7e2b795136bf59683c50d1207584f3ec4caf04a?s=96&d=mm&r=g","caption":"Femama"}}]}},"_links":{"self":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/26654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/comments?post=26654"}],"version-history":[{"count":10,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/26654\/revisions"}],"predecessor-version":[{"id":26684,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/posts\/26654\/revisions\/26684"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media\/26655"}],"wp:attachment":[{"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/media?parent=26654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/categories?post=26654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/femama.org.br\/site\/wp-json\/wp\/v2\/tags?post=26654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}